Effect of Helicobacter Pylori Infection on Nutrition, Metabolism, Cognition, and Serum Vitamin B12 in the Elderly

Document Type : Original Article

Authors

1 INTERNAL MEDICINE , GERIATRICS, FACULTY OF MEDICINE, ALEXANDRIA UNIVERSITY, EGYPT

2 Geriatric department, Alexandria Main University Hospital, Alexandria, Egypt

3 Geriatric department, Faculty of Medicine, Alexandria University

4 Clinical and Chemical Pathology Department. Faculty of Medicine, Alexandria University

Abstract

Abstract
Background: Helicobacter pylori (H. pylori) infection is one of the most common infections in humans. The rate of H. pylori infection and its complications are increasing with age worldwide. Many articles have published on the fascinating topic of extra-gastroduodenal manifestations of H. pylori infection, most of which are commonly seen in elderly population.
Aim: To investigate the effect of H. pylori infection on nutrition, metabolism, cognition, and serum vitamin B12 in the elderly.
Subjects and Methods: This study was conducted on 30 elderly patients with H. pylori infection diagnosed by stool antigen test and 30 healthy control subjects matched for age, sex and socioeconomic status. Full history, complete physical examination, anthropometric measurements, laboratory parameters (routine laboratory investigation, metabolic parameters, serum iron level, serum vitamin B12 level), and HOMA-IR score. Moreover, all participants fulfilled the mini mental state examination (MMSE) questionnaire and mini nutritional assessment (MNA) questionnaire.
Results: the results show that patients with H. pylori infection had significantly lower hemoglobin level, lower serum iron level, lower vitamin B12 level, higher insulin level, and higher prevalence of insulin resistance (defined as a HOMA-IR score ≥2.5). There were no significant differences between both groups regarding the mean MMSE score, the mean MNA score, or the prevalence of metabolic syndrome according to the definition of the National Cholesterol Education Program Adult Treatment Panel III.
Conclusion: H. pylori seems to be associated with iron deficiency anemia, vitamin 12 deficiency and insulin resistance in the elderly.

Keywords


Introduction

H. pylori infection is one of the most common infections in humans, affecting more than half of the population.  Many articles have been published on the fascinating topic of extra-gastroduodenal manifestations of H. pylori infection[1].

 H. pylori infection can cause deficiencies in vitamins and essential minerals [2]. Several studies have revealed an association between H. pylori infection and iron- deficiency anemia. Moreover, elderly people are particularly at risk of vitamin B12 deficiency. Studies have demonstrated a link between chronic H. pylori infection and malabsorption of vitamin B12 [3], and an increased prevalence of Mets. [4].  

Subjects

This analytical case control study was conducted on 60 subjects above the age of 65 years and divided into two groups; 30 elderly patients with H. pylori infection diagnosed by stool antigen test and 30 healthy control subjects matched for age, sex and socioeconomic status.

Exclusion criteria included; severe renal or liver impairment, chronic debilitating disease (severe renal impairment, advanced liver disease, advanced heart failure, chronic severe bronchial asthma, cerebrovascular stroke), thyroid diseases, history of eradication treatment for H. pylori, malignant diseases, and history of previous gastrointestinal surgery. Informed consent was obtained from all patients who participated in the study.

Methods

This study was conducted between May 2018 and June 2019. All patients were subjected to full history taking (with special stress on complaints of epigastric pain, heartburn, dyspepsia, vomiting, hematemesis, melena and loss of weight, history of H.pylori infection and with treatment, drug history, disease historyand surgical history) and complete physical examination.

Anthropometric measurements of all participants were taken and included:

  • Body weight, height and Body Mass Index (BMI) were calculated as weight in kg / (height in m2.
  • Mid-arm circumference (midpoint of the upper arm, halfway between the tip of the acromion process and the tip of the olecranon process).

 

  • Calf circumference (Measured at the calf's greatest girth with the subject standing).
  • Waist circumference (Mid-way between the lowest rib and the iliac crest with the subject standing).

Peripheral blood samples were collected from all subjects in the morning after overnight fasting, and serum iron, fasting blood glucose (FBG), insulin, total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), Albumin (Alb), blood urea nitrogen (BUN), creatinine (Creat), CBC, and vitamin B12 were measured in serum samples.

According to the National Cholesterol Education Program Adult Treatment Panel III (NCEP/ATP III). Subjects were classified as having MetS if they had any three of the following five risk factors [5]:

  1. Waist circumference > 102 cm for men and > 88 cm for women.
  2. Triglycerides concentration ≥ 150mg/dL (or drug treatment).
  3. High density lipoprotein cholesterol (HDL-C) <40mg/dL in men and <50mg/dL in women (or drug treatment).
  4. Blood pressure ≥ 130/ 85 mm Hg (or drug treatment).
  5. Fasting glucose ≥ 100mg/dL (or drug treatment).

The homeostasis Model Assessment 2 (HOMA2) calculator was used to estimate steady state beta cell function (%B) and insulin resistance (%S) (HOMA- IR) according to the updated computer based HOMA2 mode in subjects with normal or impaired glucose tolerance. Insulin resistance was defined as a HOMA-IR score ≥2.5[6]. 

All participants completed the mini nutritional assessment (MNA) questionnaire for Nutritional assessment. The MNA is the most popular and most frequently used nutritional screening and assessment tool for the elderly.It is correlated with clinical assessment and comprehensive nutritional assessment, including biochemical tests, anthropometric measurements, and dietary assessment [7]. 

All participants completed the mini mental state examination (MMSE) questionnaire for cognition assessment. The MMSE is effective as a screening instrument that can be used to systematically and thoroughly assess cognitive impairment in older adults. The maximum score was found to be 30. A score of 24 is the most widely used cutoff for dementia [8]. 

Statistical Analysis

Data were collected, coded, revised and entered into the Statistical Package for Social Science (IBM SPSS) version 20. The data were presented as numbers and percentages for the qualitative data, mean, standard deviations and ranges for the quantitative data with parametric distribution and median with inter quartile range (IQR) for the quantitative data with non- parametric distribution. Chi-square test was used in the comparison between two groups with qualitative data and Fisher's exact test was used instead of the Chi-square test when the expected count in any cell was less than 5. An independent t-test was used for the comparison between two groups with quantitative data and parametric distribution and the Mann-Whitney test was used for the comparison between two groups with quantitative data and non-parametric distribution. Spearman correlation coefficients were used to assess the significant relationship between two the quantitative parameters in the same group. All results were interpreted at a 5% level of significance where the difference between the study groups was considered significant if P ≤ 0.05.

 

Ethical approval

The protocol was approved by the ethical committee in the faculty of medicine, Alexandria University.

Results:

Demographic data of the studied patients revealed that there was no significant statistical difference between the studied groups in terms of age (p=0.744) or gender (p=0.791). There were no significant statistical differences between the H. pylori +ve and –ve groups with regard to any of the studied anthropometric measurements including weight (Wt) (p=0.535), height (Ht) (p=0.322), body mass index (BMI) (p=0.510), mid-arm circumference (MAC) (p=0.525), calf circumference (p=0.592) waist circumference (WC) (p=0.351) (table1).

 

Table (1):   The demographic characteristics and anthropometric measurements of study groups

 

H.pylori +ve

(No.=30)

H.pylori –ve

(No.=30)

P value

Mean ±SD

Mean ±SD

Age

69.20±3.54

68.93±3.62

0.774

Gender

 

 

 

Female (No)

Male (No)

11(36.70%)

19(63.30%)

12(40.00%)

18(60.00%)

0.791

Wt. (Kg)

79.47±10.80

77.60±12.33

0.535

Ht. (m)

1.66±0.08

7.43±31.65

0.322

BMI (Kg/m2)

28.79±4.10

28.07±4.32

0.510

MAC (Cm)

28.43±3.46

29±3.40

0.525

Calf circum (Cm)

36.40±5.11

35.77±3.91

0.592

WC (Cm)

101.77±12.95

98.40±14.75

0.351

Regarding the clinical characteristics of the study participants; H. pylori +ve subjects had significantly lower serum hemoglobin levels than H.pylori –ve  subjects (p=0.001) but there were no statistically significant differences regarding platelets (p=0.093), WBC (p=0.236), serum albumin (0.245), cholesterol (p=0.149), LDL (p=0.129), HDL (p=0.242), TG (p=0.148), creatinine.(p=0.650), BUN (p=0.701), and CRP (P=0112) between the two groups. Serum iron levels were significantly lower in the H. pylori +ve group (p=0.001) while there was no statistically significant difference between the two groups regarding FBS (P=0.192). Insulin levels were statistically significant higher in the H. pylori +ve Group (p=0.017) but there was no statistical significant difference between the two studied groups regarding HOMA-IR (p=0.079) or MNA (p=0,573) (table 2).

 

 

Table (2): clinical characteristics of the study population.

 

H. pylori +ve

(No.=30)

H. pylori –ve

(No.=30)

 

Mean ± SD

Mean ± SD

P value

Hb (g/dl)

11.68±2.08

13.39±1.12

<0.001

Plt (×103/mm3)

221.20±107.07

185.63±39.69

0.093

WBC (×103/mm3)

6.77±2.48

6.13±1.53

0.236

Alb (g/dl)

4.48±0.36

4.59±0.35

0.245

TC (mg/dl)

203.10±49.05

186.40±38.84

0.149

LDL (mg/dl)

133.27±47.24

117.00±33.48

0.129

HDL (mg/dl)

46.23±12.32

49.83±11.24

0.242

TG (mg/dl)

116.07±53.06

98.67±37.60

0.148

Creat (mg/dl)

0.93±0.26

0.90±0.22

0.650

BUN (mg/dl)

16.62±3.55

16.29±3.13

0.701

CRP (mg/dl)

7.39±10.04

4.26±3.46

0.112

Iron (µg/dl)

67.07±18.11

122.37±27.17

<0.001

FBG (mg/dl)

85.40±25.90

77.60±19.38

0.192

Insulin (µu/ml)

7.60±4.93

4.93±3.36

<0.017

HOMA-IR

1.69±1.79

1.01±1.03

0.079

MNA

26.40±1.93

26.70±2.16

0.573

MMSE

27.20 ± 2.75

28.50 ± 2.43

0.057

                *: Statistically significant at p ≤ 0.05

In this study B12 level was <200pg/ml in 50% of H. pylori +ve cases and >200 pg/ml in the other 50% of the same cases but all H pylori –ve cases had B12>200pg/ml.B12 level was statistically significant lower in H pylori +ve group (p=0.001) (table 3).

Table (3): Comparison between H. pylori +ve &-ve cases as regards Vitamin B12 level

 

H pylori +ve

(No.=30)

No(%)

H pylori –ve

(No.=30)

No(%)

Chi square test

Independent test

X2/t*(p value)

B12 (pg/ml)       

 

 

 

<200

15 (50.0%)

0(0.0%)

20.000(0.001*)

>200

15 (50.0%)

30 (100.0%)

B12

 

 

 

Mean± SD

207.82±139.54

510.27±127.00

-8.780(0.001*)

Range

50-629

243-701

               *: Statistically significant at p ≤ 0.05

Regarding IR 80% of H. pylori +ve cases were insulin sensitive and 20% were insulin resistant but H pylori –ve cases only 3.30% had insulin -resistant, so H. pylori +ve cases had statistically significant IR than H pylori –ve cases (p=0.044). 30.0% of H. pylori +ve cases had MetS while 26.70% of H pylori –ve had MetS with no statistical significant difference between the two groups (p=0.774). About 83.3% of H. pylori +ve cases had MMSE ≥24 and only 16.7% had MMSE<24 but in H pylori –ve cases only 3.3% were found to have MMSE<24 with no statistically significant difference between the two groups regarding MMSE (0.085) (table 4).

Table (4): Comparison between H. pylori +ve &-ve cases as regards IN and Mets

 

H pylori +ve

(No.=30)

H pylori –ve

(No.=30)

Chi square test

No (%)

No (%)

X2(p)

IR

 

 

 

Isulin sensetive

24(80.0%)

29(96.7%)

4.043(0.044*)

Insulin resistant

6(20.0%)

1(3.3%)

Mets

 

 

 

Normal

21(70.0%)

22(73.3%)

0.082(0.774)

Metabolic syndrome

9(30.0%)

8(26.7%)

<24

5(16.7%)

1(3.3%)

X2/t*(p)

2.963(0.085)

≥24

25(83.3%)

29(96.7%)

MMSE Score

 

 

 

Mean±SD

27.20±2.75

28.50±2.43

-1.941(0.057)

Range

23-30

21-30

IR: Insulin resistance

Mets: metabolic syndrome

MMSE: Minimental Status Examination score

Discussion:

H. pylori infection is one of the most common infections in humans, affecting more than half of the population. Recently, many articles have published on the fascinating topic of extra-gastroduodenal manifestations of H. pylori infection, including hematological, metabolic, cardiovascular, neurodegenerative and allergic disorders.

The present study was conducted on 60 subjects above the age of 65 years divided into two groups; 30 elderly patients with H. pylori infection diagnosed by stool antigen test and 30 healthy control subjects matched for age, sex and socioeconomic status.

The results revealed that no statistically significant differences were determined between the H. pylori +ve and –ve groups regarding gender or age. This balance in the baseline characteristics offered the basis to compare the study groups as it helped decreasing bias. 

The nutritional status of the patients, was assessed through anthropometric measurements, MNA score, along with laboratory indices (such as serum albumin, TC, TG, BUN, Vit B12, serum iron and Hb level). Various nutritional indices had been used in the assessment of nutritional status in previous researches that studied the impact of H. pylori infection on nutritional status of old patients, but MNA score had not been used.

The nutritional status, evaluated by the assessment of: BMI, mid arm muscle area, serum albumin, vitamin B12, folate, iron, ferritin, transferrin, and Hb, was not affected by the existence of anti-H. pylori IgG in a study that was carried out by D Mustafa [9]. In addition, no correlations were detected between H. pylori infection and nutritional indices (including BMI, mid arm muscle area, triceps skin fold, serum prealbumin& albumin, FBG, BUN, Hb, iron, and transferrin) in a study that carried out on 96 patients in a geriatric institute [10]. From the previous two studies, the results of this study comply with some findings (as anthropometric measurements, serum albumin, FBG, BUN, TC and TG) and was in contrast to other parameters in the same study (as serum iron, Hb level and serum vitamin B12).

The present study revealed that no statistically significant differences were found between the H. pylori +ve and –ve groups regarding any of the studied anthropometric measurements including Wt, Ht, BMI, mid-arm circumference, calf circumference and WC. These findings came in line with those of the cross-sectional study that was done by Upala et al [11] on 1,300 elderlies, average age of 69.23 ± 7.31, revealed that H. pylori infection wasn’t related to BMI. However, Yang et al [12] revealed that H. pylori infection ensured by gastric biopsy histopathology was associated with obesity assessed by BMI in elderly Chinese individuals.

 

 

Anemia is one of the complications of H. pylori infection. There are various mechanisms explaining the relationship between H. pylori infection and anemia. The most accepted one is gastrointestinal blood loss as a result of H. pylori- induced gastritis or duodenitis. In addition to the iron sequestration by H. pylori and H. pylori induced food cobalamin malabsorption [13]. 

The results of this study showed that elderly patients with H. pylori +ve infection had significantly lower haemoglobin (Hb) levels compared with controls. These results were in agreement with what study done by Muhsen K [14] in a cross-sectional study that was performed on 646 asymptomatic elderly males (mean age= 79.4± 8.9, range= 65-100 years) and found that the prevalence of anemia (Hb cutoff value of 120 g/L) in the H. pylori +ve group, was significantly elevated in comparison with that in -ve group (5.3% vs. 2.2%, P= 0.033). In contrast to results of this study no significant difference in Hb level according to H. pylori status was reported in a recent study which enrolled 50 patients with positive H. pylori biopsy result and 50 healthy controls as it found a slight non-significant decrease in Hb level in H. pylori (+ve) cases versus controls in a study performed by Boyanova L [15].These contradictory results can be explained by the fact that Hb level could be within normal ranges with very low or absent iron stores as Hb level is kept within normal range till the body iron stores are depleted. 

As for serum iron level, these results showed that elderly patients with H. pylori infection had significantly lower iron level compared with controls. The causal relation between the H. pylori infection and iron deficient anemia (IDA) can be explained by several mechanisms. First, the uptake of iron by the bacteria is induced during the bacterial growth [16].    Second, it has been proved that Cag A protein participates in iron acquisition from interstitial holotransferrin. In addition to blood loss as a result of chronic erosive gastritis and reduced iron absorption caused by chronic active gastritis and hypochlorhydra [17].   

These findings comply with a study performed by Mwafy et al [ 18] who investigated 150 H. pylori +ve patients (confirmed by positive stool antigen test) and 150 matched controls for several hematologic parameters, and they reported significantly reduced level of iron in patients with H. pylori in comparison with uninfected subjects (71.6 ± 24.8 vs 80.1 ± 20.7 μg/dL). Similar results found that H. pylori infected patients (diagnosed by rapid urease test) had a significantly decreased mean serum ferritin level in comparison with non-infected cases (P<0.001). A study which was conducted by John S on 168 subjects had also documented a significant decreased value of mean MCV and MCH in H. pylori +ve patients (P<0.001)  [19].

Nevertheless, Goddard AF and et al who performed their study on 523 subjects, did not find an association between unexplained ID or IDA and H. pylori infection (diagnosed by rapid urease test or histology) in older adult without peptic ulcer disease or significant upper gastrointestinal source of blood loss. In summary, the association of H. pylori and IDA was proved in several studies. Current international as well as national guidelines recommend treatment of the infection in patients suffering unexplained IDA [20]. The current study proved that elderly patients with H. pylori infection had significantly lower mean vitamin B12 level and significantly higher prevalence of vitamin B12 deficiency compared with controls.

Chronic H. pylori infection with intestinal microbial proliferation is an important factor that participates in food-cobalamin malabsorption in old patients. And this could be explained by several mechanisms; 1) H. pylori is potentially related with chronic active gastritis of the gastric antrum causing impaired gastric acid and pepsin secretion resulting in malabsorption of vitamin B12. 2) H. pylori also contribute in the development of gastric ulcers which hinder the absorption of consumed vitamin B12. 3) The hypochlorhydria accompanied by atrophic gastritis might result in inability to split B12 from food binders and its subsequent transport to salivary R-binder in the stomach, thereby causing B12 malabsorption [21]. 

In agreement with these results, a case-control study that was carried out by El Demerdash [22] on 120 subjects demonstrated that the mean serum vitamin B12 level in the H. pylori +ve group was significantly lower than that in the -ve group (278±110 versus 590±128, respectively P= 0.0002). Also, a case-control study that involved 300 subjects found that H. pylori infected subjects had significantly lower mean serum vitamin B12 compared to controls (262.5 ± 100.0 vs. 378.2 ± 160.6 pg/mL, respectively, p <0.001). And vitamin B12 elevated significantly and was restored to near normal level following therapy.

The current study revealed a higher mean insulin level and a higher prevalence of insulin resistance (IR) in the H. pylori +ve group compared to H. pylori -ve group. Meanwhile, no statistically significant differences were found between both groups regarding the prevalence of metabolic syndrome (MetS) according to the definition of NCEP/ATP III.

The mechanism that links H. pylori infection and IR isn’t clear; however, a chronic inflammatory response and the accompanying cytokine release after H. pylori infection might be account for IR pathogenesis. 

The results of the current study came in agreement with a study that conducted by Chen NW [23]  as it demonstrated that H. pylori seropositivity was obviously elevated in cases with insulin resistance (HOMA-IR ≥ 2.5) in comparison with cases without IR (HOMA-IR <2.5) (39.4 vs 28.7%, p=0.027).  Similar results were also reported in a community-based cohort study performed by Allam [24] who found that subjects with the H. pylori antibody had higher rates of insulin resistance (HOMA-IR >2.5) when compared with individuals without the H. pylori antibody. 

 

 

On the contrary to the current study results, Naja et al [ 25] concluded that the prevalence of H. pylori infection was not significantly different between insulin sensitive (HOMA-IR score <2.5) and insulin resistant (HOMA-IR score ≥2.5) participants (56.1 and 47.2%, p >0.05), they also reported that there were no significant difference between H. pylori seropositive participants and H. pylori seronegative participants according to mean fasting  serum  insulin  level (21.07 ± 9.29 and 24.45 ± 19.38 μU/mL, P >0.05). 

  In agreement to the results of this study, a cross-sectional study that was conducted on 211 subjects showed that the prevalence of MetS (based on the International Diabetes Federation criteria) among H. pylori +ve and H. pylori -ve patients was 76.6% versus. 69.8% (p=0.27), according to NCEP-ATPIII criteria it was 90.4% vs. 87.2% (p=0.5), and the differences was not significant [26]. In addition, Kim et al. [27] showed that H. pylori seropositivity was not associated with the presence of metabolic syndrome among 37,263 subjects (according to the NCEP ATP III criteria).

However, the relation between H. pylori infection and MetS has been proved by many investigations with contradictory results to these study. A study that was performed on 191 Chinese elderly (mean age of 73.19± 11.03 years) demonstrated that participants with H. pylori infection had a higher rate of MetS than those without H. pylori infection (53.75% vs 37.84%, P<0.001) [28]. In this study the diagnosis of H. pylori infection was confirmed by histopathological examination and the rapid urease test, and MetS was diagnosed using the China Adult Dyslipidemia Prevention Guide on MetS. [29]. In addition, a Community-Based Study which was carried out on 2113 individuals, the mean age was 56.4±13.0 years, found that participants with MetS (based on the ATP III criteria) had a higher rate of H pylori infection (diagnosed by13C-UBT) than those without MetS (60.1% vs 50.8%, P<0.001) [30]. This difference between results might be explained by the difference in the age of included subjects, and the various screening approaches for H. pylori infection among different studies.

Finally, the present study revealed that no statistically significant difference was found between the H. pylori +ve and –ve groups as regards the mean MMSE score nor in the percentage of cases with abnormal low MMSE score (<24).

Similar to results of this study, no significant differences were found between H. pylori +ve and -ve patients regarding to cognitive functions which were assessed by Neri MC [9] using the Short Portable Mental Status Questionnaire (SPMSQ). In addition, a cross- sectional study conducted on 1514 person with an average age of 69.3±7.4 years reported that no significant relation was determined between the level of H. pylori antibody and MMSE score (r = 0.039, P = 0.129).

On the other hand, in a study carried out in France with a sample of 53 patients suffering AD, Roubaud-Baudron et al. reported that H. pylori infection was related to reduced MMSE score (P= 0.024) [31].

Conclusion:

In conclusion: H. pylori seems to be associated with iron deficiency anemia, vitamin 12 deficiency and insulin resistance in the elderly. Further clinical studies are needed to verify the associations and to disclose the underlying mechanisms, taking into account the bacterial virulence factors and the host genetic polymorphisms.

Conflict of interest:

Authors declare that there is no conflict of interest.

  1. Pellicano R, Ianiro G, Fagoonee S, Settanni CR, Gasbarrini A. Review: Extragastric diseases and Helicobacter pylori. Helicobacter 2020; 25(1): e12741.
    https://doi.org/10.1111/hel.12741
  2. White JV, Guenter P, Jensen G, Malone A, Schofield M. Consensus statement of the Academy of Nutrition and Dietetics/American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). J Acad Nutr Diet 2012; 112: 730-8.
    https://doi.org/10.1016/j.jand.2012.03.012
  3. Hussein, N.R. Helicobacter pylori and Gastric Cancer in the Middle East: A New Enigma? World Journal Gastroenterology.2010 16, 3226-3234.
    https://doi.org/10.3748/wjg.v16.i26.3226
  4. Viscogliosi G, Donfrancesco C, Palmieri L, Giampaoli S. The metabolic syndrome and 10-year cognitive and functional decline in very old men. A population based study. Archives of Gerontology and Geriatrics 2017; 70: 62– 6.
    https://doi.org/10.1016/j.archger.2016.12.008
  5. Kim JY, Yi ES. Analysis of the relationship between physical activity and metabolic syndrome risk factors in adults with intellectual disabilities. J Exerc Rehabil. 2018 Aug;14(4):592-597.
    https://doi.org/10.12965/jer.1836302.151
  6. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004; 27:1487–1495.https://doi.org/10.2337/diacare.27.6.1487
  7. Cereda E, Pedrolli C, Klersy C, Bonardi C, Quarleri L, Cappello S, et al. Nutritional status in older persons according to healthcare setting: a systematic review and meta-analysis of prevalence data using MNA®. Clin Nutr 2016; 35(6):1282- 90.
    https://doi.org/10.1016/j.clnu.2016.03.008
  8. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biological Psychiatry 2008;64(10):871‐9. [PUBMED: 18723162]
    https://doi.org/10.1016/j.biopsych.2008.06.020
  9. Mustafa Akcam Helicobacter pylori and micronutrients. Indian Pediatr. 2010 Feb;47(2):119-26.https://doi.org/10.1007/s13312-010-0017-2
  10. Sedgwick P. Randomised controlled trials: Balance in baseline characteristics. BMJ. 2014; 349(3):g5721.https://doi.org/10.1136/bmj.g5721
  11. Upala, Sikarin Sanguankeo, Anawin, Saleem, Sheikh A., Jaruvongvanich, Veeravich. Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology, Volume 29, Number 2, February 2017, pp. 153-159(7)
    https://doi.org/10.1097/meg.0000000000000774
  12. Yang GH, Wu JS, Yang YC, Huang YH, Lu FH, Chang CJ. Obesity associated with increased risk of gastric Helicobacter pylori infection in an elderly Chinese population. J Am Geriatr Soc 2014; 62(1):190-2.https://doi.org/10.1111/jgs.12618
  13. Xu MY, Cao B, Yuan BS, Yin J, Liu L, Lu QB. Association of anaemia with Helicobacter pylori infection: A retrospective study. Sci Rep 2017; 7:13434.
    https://doi.org/10.1038/s41598-017-13955-3
  14. Muhsen K, Cohen D. Helicobacter pylori infection and iron stores: a systematic review and meta-analysis. Helicobacter 2008; 13(5):323-40. https://doi.org/10.1111/j.1523-5378.2008.00617.x
  15. Boyanova L. Role of helicobacter pylori virulence factors for iron acquisition from gastric epithelial cells of the host and impact on bacterial colonization. Future Microbiol 2011; 6(8):843– 6.https://doi.org/10.2217/fmb.11.75
  16. Ciacci C, Sabbatini F, Cavallaro R, Castiglione F, Di Bella S, Iovino P. Helicobacter pylori impairs iron absorption in infected individuals. Dig Liver Dis 2004; 36(7):455- 60.
    https://doi.org/10.1016/j.dld.2004.02.008
  17. Daniel S Tseng, Dan Li, Sri M Cholleti, Julia C Wei, Yves Jodesty, and Hung-Viet Pham. Effect of Helicobacter pylori Treatment on Unexplained Iron Deficiency Anemia. Perm J. 2019; 23: 18-195.https://doi.org/10.7812/tpp/18-195
  18. Mwafy SN, Afana WM. Hematological parameters, serum iron and vitamin B12 levels in hospitalized Palastinian adult patients infected with Helcobacter pylori: a case control study. Hematol Transfus Cell Ther 2018;40(2):160-5. https://doi.org/10.1016/j.htct.2017.11.010
  19. ohn S, Baltodano JD, Mehta N, Mark K, Murthy U. Unexplained iron deficiency anemia: does Helicobacter pylori have a role to play. Gastroenterol Rep 2018; 6:215-20.
    https://doi.org/10.1093/gastro/goy001
  20. Goddard AF, James MW, Mclntyre AS, Scott BB. Guidelines for the management of iron deficiency anemia. Gut 2011; 60(10):1309-16.
  21. Kadhim G, Maidin MS, Omar H, Ismail A. Identification of vitamin B12 deficiency in Helicobacter pylori infected patients. J Bioengin Biomed Sci. 2015; 5(3):160.
    https://doi.org/10.4236/oalib.1104172
  22. El Demerdash DM, Ibrahim H, Hasan DM, Moustafa H, Tawfik NM. Helicobacter pylori associated to unexplained or refractory iron deficiency anemia: An Egyptian single-center experience. Hematol Transfus Cell Ther 2018;40(3):219-25.
    https://doi.org/10.1016/j.htct.2018.02.001
  23. Chen TP, Hung HF, Chen MK, Lai HH, Hsu WF, Huang KC, et al. Helicobacter pylori infection is positively associated with metabolic syndrome in Taiwanese adults: a cross-sectional study. Helicobacter 2015; 20(3):184-91.https://doi.org/10.1111/hel.12190
  24. Allam, Ahmed S; Bawady, Somia Abdel-Moaty, Ahmed S., El-Nakeep, SarahEffect ofHelicobacter pylori on insulin resistance in nonobese, nondiabetic, and normolipidemic Egyptian patient.Egyptian Liver Journal: January 2018 - Volume 8 - Issue 1 - p 23-28doi: 10.1097/01.ELX.0000530582.25024.9fs
  25. Naja F, Nasreddine L, Hwalla N, Moghames P, Shoaib H, Fatfat M, et al. Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter 2012; 17:444-51.
  26. Kapil U, Khandelwal R, Ramakrishnan L, Khenduja P, Gupta A, Sareen N, et al. Prevalence of metabolic syndrome and associated risk factors among geriatric population living in a high altitude region of rural Uttarakhand, India. J Fam Medicine Prim Care 2018; 7(4):709-16.https://doi.org/10.4103/jfmpc.jfmpc_261_17
  27. Kim TJ, Lee H, Kang M, Kim JE, Choi YH, Min YW, et al. Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease. Sci Rep 2016; 6:38015.https://doi.org/10.1038/srep38015
  28. Shin DW, Kwon HT, Kang JM, Park JH, Choi HC, Park MS, et al. Association between metabolic syndrome and Helicobacter pylori infection diagnosed by histologic status and serological status. J Clin Gastroenterol 2012; 46:840-5. https://doi.org/10.1097/mcg.0b013e3182522477
  29. Polyzos SA, Kountouras J, Zavos C and Deretzi G. The association between Helicobacter pylori infection and insulin resistance: A systematic review. Helicobacter 2011; 16(2):79-88. https://doi.org/10.1111/j.1523-5378.2011.00822.x
  30. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, et al. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 2009; 14(5):144-50. https://doi.org/10.1111/j.1523-5378.2009.00705.x
  31. Roubaud-Baudron C, Krolak-Salmon P, Quadrio I, Megraud F, Salles N. Impact of chronic Helicobacter pylori infection on Alzheimer’s disease: preliminary results. Neurobiol Aging 2012; 33(5):11-9. https://doi.org/10.1016/j.neurobiolaging.2011.10.021